Bioengineered Nisin A Derivatives Display Enhanced Activity against Clinical Neonatal Pathogens

Neonatal infection is a significant cause of mortality and morbidity in infants. The global incidence of multi-drug resistance continues to rise among neonatal pathogens, indicating a need for alternative treatment strategies. Nisin is an antimicrobial peptide that exhibits broad-spectrum activity a...

Descripción completa

Detalles Bibliográficos
Autores principales: Desmond, Anna, O’Halloran, Fiona, Cotter, Lesley, Hill, Colin, Field, Des
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686653/
https://www.ncbi.nlm.nih.gov/pubmed/36358171
http://dx.doi.org/10.3390/antibiotics11111516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686653/
https://www.ncbi.nlm.nih.gov/pubmed/36358171
http://dx.doi.org/10.3390/antibiotics11111516

Ejemplares similares